RadioMedix's Grant

RadioMedix raised a round of funding on August 27, 2015. Investors include National Cancer Institute.

RadioMedix is a clinical phase biotechnology company focused on commercialization of innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is interested…

Articles about RadioMedix's Grant: